PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 500.00 thousand shares for the 12-month period ending 2019-07-31, per its 10-K filed 2020-10-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2020-10-08
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2019 was 500.00K shares, a 33.33% decline from fiscal 2018.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 750.00K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2015 was 600.00K shares, a 90.37% decline from fiscal 2014.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was 6.23M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month as first filed |
|---|---|---|
| 2019-07-31 | 500.00K shares 10-K · filed 2020-10-08 | 725.00K shares 10-K · filed 2019-10-30 |
| 2018-07-31 | 750.00K shares 10-K · filed 2019-10-30 | |
| 2015-07-31 | 600.00K shares 10-K · filed 2015-10-28 | |
| 2014-07-31 | 6.23M shares 10-K · filed 2015-10-28 |